ID NOW™ RSV (formerly Alere™ i RSV)
There is no time like ID NOW.
Good test, great after purchase care.
Point of Care Testing
Good test for pediatric and geriatric populations. Great after purchase care.
Review Date: 20 Dec 2021 | Abbott
Great product. Excited to go molecular with more sensitive results.
Analyze nasopharyngeal specimens for RSV
Easy to use, just like the influenza product. Quick results. Kit comes with all supplies needed.
Review Date: 1 Nov 2018 | Abbott
I would recommend strongly in my publicaitons
Molecular Diagnostics
It enabled high quality results with ease of use.
Review Date: 3 Aug 2017 | Abbott
Glad we switched to the Alere I for our RSV and Influenza
Hospital Lab
Very easy to use and more accurate than our previous rapid RSV kits
Review Date: 3 Aug 2017 | Abbott
Great product!
RSV Testing
We love that if positive you don't have to wait the full 10mins!
Review Date: 3 Aug 2017 | Abbott
We are very happy with this system.
Emergency and outpatient
Analyzer is easy to use, very user friendly. closed disposable system with very little maintenance. Manufacturer support is excellent.
Review Date: 3 Aug 2017 | Abbott
Great product, good price point!
ED samples
Easy and fast to use, I would highly recommend to others
Review Date: 3 Aug 2017 | Abbott
New test addition to the Alere i line with hopefully more to come.
Main lab testing with intent to include after hours clinic with season this fall volume.
Though it is more involved than previous method it still maintains user friendliness with an improvement in results that more than justify the change.
Review Date: 3 Aug 2017 | Abbott
Better sensitivity and ease of use in clinical settings
ED and NICU patients
Better sensitivity and ease of use in clinical settings
Review Date: 3 Aug 2017 | Abbott
RSV Molecular Test Now CLIA Waived. Plus a new name.
ID NOW™ RSV delivers molecular RSV results in 13 minutes or less on our unique ID NOW™ platform. Traditional laboratory methods and rapid antigen testing for RSV diagnosis have considerable shortcomings in terms of turnaround time or performance. 1,2 ID NOW™ RSV detects 25% more true positives than Rapid Antigen Detection Tests (RADTs) 3,4 and allows you to make real-time clinical decisions which impact patient care.
1. Prendegast, C. et al. Rapid Antigen-based Testing for Respiratory Syncytial Virus; Moving Diagnostics From Bench to Bedside? Future Microbiol, 2013;8(4):435-444.
2.Caliendo, A.M. et al. Better Tests, Better Care: Improved Diagnosis for Infectious Disease. Clin Infect Dis 2013;57(S3):S139-70.
3.Chartrand, C. et al. Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysis. J Clin Microbiol. Dec 2015 vol. 53 no. 12 3738-3749.
4.Alere™ i RSV Package Insert
TO GET MORE FROM YOUR POC TESTING, CONNECT IT.
Connect More, Share More, Worry Less
A web-based, open platform, AegisPOC™ lets you better manage and share data from your POC devices on one flexible, scalable middleware. AegisPOC provides you with the ability to integrate POC devices with LIS, HIS, EMR, quality management, user management and other systems. Not available in the USA.